Email: success@optimetabolics.com
This article is part of Opti Metabolics’ ongoing effort to translate complex metabolic research into clear, practical insights for readers without formal scientific or medical training.
This comprehensive analysis of NHANES data from 1999 to 2018 reveals that fewer than 7% of U.S. adults maintain optimal cardiometabolic health, and this rate has significantly declined over time. The findings expose worsening trends in metabolic dysfunction—particularly in abdominal adiposity, glucose regulation, and insulin sensitivity—while also highlighting widening disparities based on age, sex, ethnicity, and socioeconomic status.
– As of 2017–2018, only 6.8% of U.S. adults had optimal cardiometabolic health.
– Cardiometabolic health was defined across five domains: adiposity, blood pressure, blood glucose, blood lipids, and absence of clinical cardiovascular disease.
– From 1999 to 2018, cardiometabolic health declined significantly, primarily due to worsening waist circumference and blood glucose levels.
– Abdominal adiposity worsened across all demographic groups, reflecting increased insulin resistance and poor dietary quality.
– Optimal fasting glucose status declined from 59.4% to 36.9% over the study period, indicating a sharp rise in prediabetes and diabetes.
– Only 24% of adults had normal waist circumference by 2018, signaling a growing prevalence of visceral fat.
– Cardiometabolic disparities widened by age, sex, education, and race/ethnicity over time.
– Non-Hispanic White adults had the highest rates of cardiometabolic health, while Hispanic and Black adults had disproportionately lower rates.
– Adults with higher income and education levels showed better cardiometabolic outcomes.
– Younger adults (20–34) experienced notable declines in glucose and adiposity status, revealing early-onset metabolic impairment.
– Lipid profiles improved modestly, likely due to increased statin use rather than lifestyle changes.
– Clinical ASCVD prevalence increased, highlighting the failure of traditional risk management strategies to prevent disease.
– Poor cardiometabolic health was prevalent even among individuals without diagnosed chronic illness.
– The authors called for transformative approaches targeting dietary patterns and lifestyle, not just medical interventions.
– Prevention strategies should begin earlier in life and focus on systemic, root-cause drivers of metabolic disease.
This study confirms a dramatic and ongoing collapse of metabolic health in the U.S. population, even among those not yet diagnosed with chronic disease. Opti Metabolics directly addresses these underlying dysfunctions—insulin resistance, visceral adiposity, and chronic inflammation—through targeted, low-carbohydrate, anti-inflammatory strategies that support metabolic recovery at the root level.
– Reinforces the central role of insulin resistance and abdominal adiposity in driving cardiometabolic decline.
– Supports The Purple Zone framework of personalizing interventions based on metabolic biomarkers rather than treating downstream disease symptoms.
– Highlights the failure of conventional guidelines and pharmacotherapy alone to reverse population-level health trends, validating Opti Metabolics’ food-first, systems-based approach.
Reviewed and interpreted by the Opti Metabolics editorial team, with a focus on early metabolic risk detection and prevention.
Read the article to learn more: Trends and Disparities in Cardiometabolic Health Among U.S. Adults, 1999-2018
Opti Metabolics does not provide medical diagnosis, treatment, or advice. Our program is for educational and informational purposes only and does not represent medical advice or the practice of medicine. These article summaries are intended to help readers understand metabolic health research and emerging scientific findings, but personal health decisions should always be made in consultation with a qualified healthcare provider.
Participants are strongly advised to consult their personal healthcare professional before making any dietary, lifestyle, or medication changes.
Email: info@optimetabolics.com
Your results suggest early signs of metabolic dysfunction are emerging beneath the surface.
While you may feel healthy today, several biomarkers indicate increasing risk for insulin resistance, cardiovascular disease, and other chronic conditions if these patterns continue to progress.
The encouraging news is that these findings were identified before disease developed, creating an opportunity to improve your long-term health trajectory through targeted interventions.
No
Risk
Low
Risk
Medium Risk
High Risk
Higher Risk
Higher numbers indicate more biomarkers in each risk category.
We look upstream to identify and address the root drivers of chronic disease long before symptoms appear.
Excess insulin and poor cellular response drive metabolic dycfuntion and fat storage.
Imbalance between free radicals and your body's antioxidant defenses.
Chronic, low grade inflamation damages tissues and disrupts normal function.
Elevated cortisol and other stress hormones amplify the damaga and impair recovery.
Inherited factors can increase succeptbility and influence how your body responds.
Over time, these drivers create the foundation for chronic disease to take root.